Polyclonal Antibody to Deleted In Malignant Brain Tumors 1 (DMBT1) is a premium-quality life science research product supplied by Torvigen for laboratory and scientific applications.
RPJ251Hu01-Recombinant Deleted In Malignant Brain Tumors 1 (DMBT1)
Recommended Usage
Western blotting: 0.01-2μg/mL; < br/> Immunohistochemistry: 5-20μg/mL; < br/> Immunocytochemistry: 5-20μg/mL; < br/> Optimal working dilutions must be determined by end user.
